Diadema Partners’s 89bio ETNB Stock Holding History

Diadema Partners’s Portfolio ETNB Stock Details ETNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-98,382	Closed	-$966K	–	143
2025 Q2	$966K	Sell	98,382 -133,054	-57%	-$1.1M	0.29%	67
2025 Q1	$1.68M	Buy	+231,436	New	+$2.02M	0.44%	48

Other funds holding ETNB

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Diadema Partners's ETNB Position: Q3 2025 in Review

Diadema Partners sold out of 89bio (ETNB) in Q3 2025, closing a stake of 98,382 shares — an estimated $966K sold.

Diadema Partners first reported a position in ETNB in Q1 2025 and held it in 2 quarters. The position peaked at $1.68M in Q1 2025. 198 funds tracked by Wall St. Rank hold ETNB as of Q3 2025.

Diadema Partners reported no remaining 89bio position as of Q3 2025 after selling out during the quarter.
Diadema Partners sold 98,382 89bio shares in Q3 2025, an estimated $966K.
Diadema Partners first reported a position in 89bio in Q1 2025 and held it in 2 quarters.
Diadema Partners's 89bio position peaked at $1.68M in Q1 2025.
198 funds tracked by Wall St. Rank held 89bio as of Q3 2025.

Based on Diadema Partners's 13F filing for Q3 2025, filed 14 Nov 2025.